- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04035928
Digital Design for Maxillofacial Prosthetics
May 31, 2022 updated by: David Zopf, University of Michigan
Pilot Study on High Resolution 3D Digital Scanning for Maxillofacial Prosthetics for Feasibility and Efficacy
This study will use a 3D scanner to print a 3D model or mold for each patient's prosthesis.
The goal of this study to provide patients with a new, faster method of imaging and creating prostheses that preserves the quality of the current method while reducing time spent by both the patient and providers.
Patients that are eligible will have a non-invasive 3D scanner (Artec Space Spider) to image the indicated areas of their head and face to help create their new prosthesis.
Patients will come in for visits as needed to fit and adjust their prosthetic.
Additionally, patients will be asked to complete questionnaires and have follow-up visits at certain time -points pre and post prosthetic completion.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: David Zopf, MD
- Phone Number: 7349364585
- Email: davidzop@umich.edu
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48170
- Recruiting
- University of Michigan
-
Contact:
- David Zopf, MD
- Phone Number: 734-936-4585
- Email: davidzop@umich.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Maxillofacial anatomic defect or anomaly that limits function or cosmesis (including facial and/or intraoral)
- Stable defect (no clinically active tumor or plans for major reconstructive surgery)
- The patient (or family) have elected to pursue a prosthetic reconstruction of a craniofacial anomaly
- The patient is amenable to 3D surface scanning rather than facial molding
Exclusion Criteria:
- Known allergy to silicone
- Poor candidate for prosthetic reconstruction
- Developmental concerns regarding aspiration risk
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 3D digital scanning for maxillofacial prosthetics
|
The non-invasive Artec Space Spider 3D scanner will be used to image the indicated areas of the patients head and face.
In the case of an intraoral defect, the noninvasive TRIOS intraoral 3D scanner will be used.
The study may also use nasometry or nasal endoscopy to measure the amount of airflow through the patient's fistula to help guide the design.
The software that will be used will create a 3D image of the prosthesis during the patient's clinic appointment.
Once a model of the prosthesis is fully designed and manufactured, the patient will return to clinic for a second appointment which may involve fitting and coloring.
A subsequent appointment will involve delivery of a successfully fitted and colored prosthesis that the patient will take home.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number or weeks to create the final prosthesis
Time Frame: up to 6 months
|
up to 6 months
|
|
Time the participants spend in the clinic
Time Frame: up to 6 months
|
This includes time spent with participant to design the prosthetic
|
up to 6 months
|
Number of hours spent to create the prosthetic
Time Frame: up to 6 months
|
The number of hours will be calculated by using the design software, scanners, printing, and modifying the mold and prosthesis.
|
up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satisfaction measured by modified Toronto Outcome Measure of Craniofacial Prosthetics (TOMCP) for intraoral prosthesis.
Time Frame: up to 6 months after the prosthetic is completed and being used
|
Survey questions are all created using a 7-point Likert scale for assessment.
Questions 10-17 from the survey will be used to measure the patients prosthesis level of satisfaction (the higher the score the more satisfied).
These will be completed pre-prosthesis and at 1 month and 6 months post prosthesis for patients with intraoral prosthesis.
|
up to 6 months after the prosthetic is completed and being used
|
Satisfaction measured by modified Toronto Outcome Measure of Craniofacial Prosthetics (TOMCP) for extraoral prosthesis.
Time Frame: up to 6 months after the prosthetic is completed and being used
|
Survey questions are all created using a 7-point Likert scale for assessment.
Questions 8-19 from the survey will be used to measure the patients level of satisfaction (the higher the score the more satisfied).
These will be completed pre-prosthesis and at 1 month and 6 months post prosthesis for patients with extraoral prosthesis.
|
up to 6 months after the prosthetic is completed and being used
|
Quality of life measures by modified Toronto Outcome Measure of Craniofacial Prosthetics (TOMCP) for intraoral prosthesis.
Time Frame: up to 6 months after the prosthetic is completed and being used
|
Survey questions are all created using a 7-point Likert scale for assessment.
Questions 1-9 from the survey will be used to measure the patients level of quality of life (the higher score indicates better quality).
These will be completed pre-prosthesis and at 1 month and 6 months post prosthesis for patients with intraoral prosthesis.
|
up to 6 months after the prosthetic is completed and being used
|
Quality of life measures by modified Toronto Outcome Measure of Craniofacial Prosthetics (TOMCP) for extraoral prosthesis.
Time Frame: up to 6 months after the prosthetic is completed and being used
|
Survey questions are all created using a 7-point Likert scale for assessment.
Questions 1-7 from the survey will be used to measure the patients quality of life (the higher score indicates be better quality).
These will be completed pre-prosthesis and at 1 month and 6 months post prosthesis for patients with extraoral prosthesis.
|
up to 6 months after the prosthetic is completed and being used
|
Number of adverse events related to the prosthetic
Time Frame: up to 6 months after the prosthetic is completed and being used
|
This study will collect and report adverse events (serious and non-serious) at least possibly related to the prosthetic.
|
up to 6 months after the prosthetic is completed and being used
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Zopf, MD, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 14, 2019
Primary Completion (Anticipated)
July 1, 2023
Study Completion (Anticipated)
July 1, 2023
Study Registration Dates
First Submitted
July 10, 2019
First Submitted That Met QC Criteria
July 24, 2019
First Posted (Actual)
July 29, 2019
Study Record Updates
Last Update Posted (Actual)
June 2, 2022
Last Update Submitted That Met QC Criteria
May 31, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00155762
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Maxillofacial Abnormalities
-
Medipol UniversityWithdrawnMaxillofacial Abnormalities | Maxillofacial Injuries | Maxillofacial Trauma | Maxillofacial DysostosisTurkey
-
Medipol UniversityCompletedMaxillofacial Abnormalities | Maxillofacial Injuries | Maxillofacial TraumaTurkey
-
TC Erciyes UniversityCompletedMaxillofacial AbnormalitiesTurkey
-
University Hospital, Strasbourg, FranceRecruitingMaxillofacial AbnormalitiesFrance
-
Marmara UniversityRecruitingMaxillofacial AbnormalitiesTurkey
-
Cairo UniversityRecruitingDentofacial DeformitiesEgypt
-
Hassan Fahmy Hassan AlnimrRecruiting
-
Centre Hospitalier Annecy GenevoisCompletedMaxillofacial Abnormalities | Orthognathic Surgery
-
Cairo UniversityRecruiting
Clinical Trials on 3D digital scanning for maxillofacial prosthetics
-
University of RochesterTerminatedFailed or Difficult IntubationUnited States
-
University of MichiganNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Centro di Riferimento per l'Epidemiologia e la...im3D S.p.A.; Regione PiemonteUnknown